Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

2.99USD
11:48am EST
Change (% chg)

$-0.11 (-3.55%)
Prev Close
$3.10
Open
$3.15
Day's High
$3.21
Day's Low
$2.99
Volume
104,514
Avg. Vol
160,333
52-wk High
$25.00
52-wk Low
$2.14

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: 0.20
Market Cap(Mil.): $31.37
Shares Outstanding(Mil.): 10.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 49.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.18 35.74
ROE: -- 16.80 17.71

BRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device License

* TANDEM DIABETES CARE APPLIES FOR HEALTH CANADA MEDICAL DEVICE LICENSE

Feb 20 2018

BRIEF-Tandem Diabetes Care Files For Offering Of 13.5 Mln Shares Of Co's Common Stock

* TANDEM DIABETES CARE FILES FOR OFFERING OF 13.5 MILLION SHARES OF CO'S COMMON STOCK, PAR VALUE $0.001 PER SHARE - SEC FILING‍​‍​ Source text: (http://bit.ly/2nmA5Fh) Further company coverage:

Jan 29 2018

BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE

Jan 09 2018

BRIEF-Tandem Diabetes Care Says May Offer Combination Of Stock Not Exceeding $10.7 Mln

* TANDEM DIABETES CARE SAYS MAY OFFER COMBINATION OF STOCK, PREFERRED STOCK, WARRANTS OR UNITS HAVING INITIAL OFFERING PRICE NOT EXCEEDING $10.7 MILLION Source text: (http://bit.ly/2oGBPwa) Further company coverage:

Dec 18 2017

BRIEF-Tandem Diabetes Care reports Q3 sales of $27 million

* Tandem Diabetes Care reports third quarter 2017 financial results

Oct 26 2017

BRIEF-‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost

* ‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​

Oct 24 2017

BRIEF-Empery Asset Management reports 5.63 pct passive stake in Tandem Diabetes Care

* Empery Asset Management Lp reports 5.63 pct passive stake in Tandem Diabetes Care Inc as of Oct 13 - SEC filing‍​ Source text: (http://bit.ly/2hSFBfg) Further company coverage:

Oct 20 2017

BRIEF-Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln

* Sees Q3 sales about $26.5 million to $27.5 million - sec filing

Oct 13 2017

BRIEF-Tandem Diabetes Care announces proposed public offering of common stock

* Tandem Diabetes Care announces proposed underwritten public offering of common stock, Series A warrants and Series B warrants Source text for Eikon: Further company coverage:

Oct 12 2017

BRIEF-Tandem Diabetes Care‍ shareholders approv reverse stock split

* Tandem Diabetes Care Inc- ‍ shareholders subsequently approved reverse stock split at a ratio of 1-for-10​ Source text for Eikon: Further company coverage:

Oct 09 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $130.89 +0.98
Roche Holding Ltd. (ROG.S) CHF222.05 -1.25
Roche Holding Ltd. (RO.S) CHF225.80 -0.60
Insulet Corporation (PODD.OQ) $77.61 -2.85

Earnings vs. Estimates